{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:00:05Z","timestamp":1794330005294,"version":"4.9.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"State Funding for University level Health Research through Oulu University Hospital"},{"DOI":"10.13039\/501100006196","name":"University of Oulu","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Intensive care unit (ICU) patients have an increased risk of bacteremia. We aimed to investigate the 5-year outcome of ICU-acquired infections comparing them with ICU patients without new infections. Our second aim was to compare the outcome of Gram-positive, Gram-negative and fungal ICU-acquired bloodstream infections (BSIs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective registry study occurred in an academic teaching hospital during 2000\u20132017 in a mixed adult ICU consisting of patients who stayed longer than 48\u00a0h in the ICU. Data was retrieved from the ICU and hospital electronic data management systems. Three groups were included: no infection and no new antimicrobial treatment, a new ICU-acquired infection with negative blood cultures (BCs), and a new ICU-acquired BSI. A multivariable-adjusted Cox proportional hazards model was used to determine the impact of ICU-acquired infection on 5-year mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>1857 had no infection and 768 developed an ICU-acquired infection with positive BCs in 195 cases (25.4%). The adjusted HR was 2.03 (95% CI from 1.76\u20132.35, p\u2009&lt;\u20090.001) for the impact of ICU-acquired infection on 5-year mortality. The highest median sequential organ failure assessment (SOFA) was 7.0 (5.0\u20138.0) for the no-infection group, 9.0 (7.0\u201310.0) for the BC-negative ICU-acquired infection group, and 12.0 (9.0\u201315.0) for the ICU-acquired BSI patients (p\u2009&lt;\u20090.001). The crude 30-day mortalities in the no-infection, the BC-negative, and the BSI groups were 98 (5.5%), 58 (10.1%), and 51 (26.0%), respectively (p\u2009&lt;\u20090.001). The highest median SOFA for Gram-positive BSIs was 11.0 (8.0\u201313.0), for Gram-negative BSIs 13.0 (11.0\u201316.0), and for fungal BSIs 12.5 (10.0\u201316.0) (p\u2009=\u20090.01). The need for RRT was 23.2% (19) in Gram-positive, 29.8% (14) in Gram-negative, and 48.1% (25) in fungal BSIs (p\u2009=\u20090.01). The crude ICU-mortalities were 12.2% (10) in Gram-positive BSIs, 31.9% (15) in Gram-negative BSIs, and 11.5% (6) in fungal BSIs (p\u2009=\u20090.008). Patients with fungal BSI had the worst 5-year outcome, whereas the long-term outcome did not differ between Gram-positive and Gram-negative BSIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with ICU-acquired infections had three times higher 5-year mortality than non-infected ICU patients. ICU-acquired Gram-negative BSIs had the highest ICU mortality, whereas the long-term outcome did not differ between Gram-negative and Gram-positive ICU-acquired BSIs. Fungal BSI showed the worst long-term outcome.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-025-02621-w","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T16:19:10Z","timestamp":1755101950000},"page":"2727-2738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Long-term outcomes of ICU-acquired infections with a focus on bloodstream infections: a single-center retrospective registry study"],"prefix":"10.1007","volume":"53","author":[{"given":"Tero I.","family":"Ala-Kokko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana M.","family":"Karhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinikka","family":"S\u00e4lki\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Ohtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Syrj\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"6","key":"2621_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/1469-0691.12195","volume":"19","author":"M Goto","year":"2013","unstructured":"Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501\u20139. https:\/\/doi.org\/10.1111\/1469-0691.12195.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"2621_CR2","doi-asserted-by":"publisher","first-page":"e00355","DOI":"10.1128\/AAC.00355-19","volume":"63","author":"DJ Diekema","year":"2019","unstructured":"Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA, Rolston KV, Sader HS, Jones RN. The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2019;63(7):e00355-e419. https:\/\/doi.org\/10.1128\/AAC.00355-19.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2621_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/MCC.0b013e328356cefe","volume":"18","author":"JF Timsit","year":"2012","unstructured":"Timsit JF, Laupland KB. Update on bloodstream infections in ICUs. Curr Opin Crit Care. 2012;18(5):479\u201386. https:\/\/doi.org\/10.1097\/MCC.0b013e328356cefe.","journal-title":"Curr Opin Crit Care"},{"issue":"21","key":"2621_CR4","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"302","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323\u20139. https:\/\/doi.org\/10.1001\/jama.2009.1754.","journal-title":"JAMA"},{"issue":"2","key":"2621_CR5","doi-asserted-by":"publisher","first-page":"R100","DOI":"10.1186\/cc10114","volume":"15","author":"JR Prowle","year":"2011","unstructured":"Prowle JR, Echeverri JE, Ligabo EV, Sherry N, Taori GC, Crozier TM, Hart GK, Korman TM, Mayall BC, Johnson PD, Bellomo R. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care. 2011;15(2):R100. https:\/\/doi.org\/10.1186\/cc10114.","journal-title":"Crit Care"},{"issue":"6","key":"2621_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00134-024-07348-0","volume":"50","author":"N Buetti","year":"2024","unstructured":"Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, Tarik Aslan A, Leone M, Bassetti M, Conway Morris A, Arvaniti K, Paiva J-A, Ferrer R, Qiu H, Montrucchio G, Cortegiani A, Kayaaslan B, De Bus L, De Waele JJ, Jean-Fran\u00e7ois Timsit J-F, EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP), and the OUTCOMEREA Network. The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections. Intensive Care Med. 2024;50(6):873\u201389. https:\/\/doi.org\/10.1007\/s00134-024-07348-0.","journal-title":"Intensive Care Med"},{"key":"2621_CR7","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s10096-021-04215-4","volume":"40","author":"M Massart","year":"2021","unstructured":"Massart M, Wattecamps G, Moriconi M, Fillatre P. Attributable mortality of ICU-acquired bloodstream infections: a propensity-score matched analysis. Eur J Clin Microbiol Infect Dis. 2021;40:1673\u201380. https:\/\/doi.org\/10.1007\/s10096-021-04215-4.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"2621_CR8","doi-asserted-by":"publisher","first-page":"e0242921","DOI":"10.1128\/jcm.02429-21","volume":"60","author":"M Verway","year":"2022","unstructured":"Verway M, Brown KA, Marchand-Austin A, Diong C, Lee S, Langford B, Schwartz KL, MacFadden DR, Patel SN, Sander B, Johnstone J, Garber G, Daneman N. Prevalence and mortality associated with bloodstream organisms: a population-wide retrospective cohort study. J Clin Microbiol. 2022;60(4):e0242921. https:\/\/doi.org\/10.1128\/jcm.02429-21.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2621_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04750-w","volume":"27","author":"A Tang","year":"2023","unstructured":"Tang A, Shi Y, Dong Q, Wang S, Ge Y, Wang C, Gong Z, Zhang W, Chen W. Prognostic differences in sepsis caused by gram-negative bacteria and gram-positive bacteria: a systematic review and meta-analysis. Crit Care. 2023;27(1): 467. https:\/\/doi.org\/10.1186\/s13054-023-04750-w.","journal-title":"Crit Care"},{"issue":"1","key":"2621_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08387-6","volume":"23","author":"Q Guo","year":"2023","unstructured":"Guo Q, Qu P, Cui W, Liu M, Zhu H, Chen W, Sun N, Geng S, Song W, Li X, Lou A. Organism type of infection is associated with prognosis in sepsis: an analysis from the MIMIC-IV database. BMC Infect Dis. 2023;23(1): 431. https:\/\/doi.org\/10.1186\/s12879-023-08387-6.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"2621_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jhin.2004.04.031","volume":"58","author":"KB Laupland","year":"2004","unstructured":"Laupland KB, Kirkpatrick AW, Church DL, Ross T, Gregson DB. Intensive-care-unit-acquired bloodstream infections in a regional critically ill population. J Hosp Infect. 2004;58(2):137\u201345. https:\/\/doi.org\/10.1016\/j.jhin.2004.04.031.","journal-title":"J Hosp Infect"},{"issue":"11","key":"2621_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-037484","volume":"10","author":"YC Wang","year":"2020","unstructured":"Wang YC, Shih SM, Chen YT, Hsiung CA, Kuo SC. Clinical and economic impact of intensive care unit-acquired bloodstream infections in Taiwan: a nationwide population-based retrospective cohort study. BMJ Open. 2020;10(11): e037484. https:\/\/doi.org\/10.1136\/bmjopen-2020-037484.","journal-title":"BMJ Open"},{"issue":"1","key":"2621_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.4269\/ajtmh.19-0877","volume":"103","author":"H Kallel","year":"2020","unstructured":"Kallel H, Houcke S, Resiere D, Roy M, Mayence C, Mathien C, Mootien J, Demar M, Hommel D, Djossou F. Epidemiology and prognosis of intensive care unit-acquired bloodstream infection. Am J Trop Med Hyg. 2020;103(1):508\u201314. https:\/\/doi.org\/10.4269\/ajtmh.19-0877.","journal-title":"Am J Trop Med Hyg"},{"key":"2621_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00134-022-06944-2","volume":"49","author":"A Tabah","year":"2023","unstructured":"Tabah A, Buetti N, Staiquly Q, et al. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med. 2023;49:178\u201390. https:\/\/doi.org\/10.1007\/s00134-022-06944-2.","journal-title":"Intensive Care Med"},{"issue":"5","key":"2621_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s15010-014-0651-z","volume":"42","author":"SJ Lim","year":"2014","unstructured":"Lim SJ, Choi JY, Lee SJ, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS. Intensive care unit-acquired bloodstream infections: a 5-year retrospective analysis of a single tertiary care hospital in Korea. Infection. 2014;42(5):875\u201381. https:\/\/doi.org\/10.1007\/s15010-014-0651-z.","journal-title":"Infection"},{"issue":"1","key":"2621_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinf.2018.04.005","volume":"77","author":"JF McNamara","year":"2018","unstructured":"McNamara JF, Righi E, Wright H, Hartel GF, Harris PNA, Paterson DL. Long-term morbidity and mortality following bloodstream infection: a systematic literature review. J Infect. 2018;77(1):1\u20138. https:\/\/doi.org\/10.1016\/j.jinf.2018.04.005.","journal-title":"J Infect"},{"issue":"8","key":"2621_CR17","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1017\/ice.2017.106","volume":"38","author":"M Jansson","year":"2017","unstructured":"Jansson M, Ala-Kokko T, Ahvenj\u00e4rvi L, Karhu J, Ohtonen P, Syrj\u00e4l\u00e4 H. What is the applicability of a novel surveillance concept of ventilator-associated events? Infect Control Hosp Epidemiol. 2017;38(8):983\u20138. https:\/\/doi.org\/10.1017\/ice.2017.106.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4 Suppl 1","key":"2621_CR18","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ajic.2011.01.003","volume":"39","author":"NP O\u2019Grady","year":"2011","unstructured":"O\u2019Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, Healthcare Infection Control Practices Advisory Committee. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4 Suppl 1):S1-34. https:\/\/doi.org\/10.1016\/j.ajic.2011.01.003.","journal-title":"Am J Infect Control"},{"issue":"8","key":"2621_CR19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/0885066618781304","volume":"35","author":"AF Tyson","year":"2020","unstructured":"Tyson AF, Campbell EF, Spangler LR, Ross SW, Reinke CE, Passaretti CL, Sing RF. Implementation of a nurse-driven protocol for catheter removal to decrease catheter-associated urinary tract infection rate in a surgical trauma ICU. J Intensive Care Med. 2020;35(8):738\u201344. https:\/\/doi.org\/10.1177\/0885066618781304.","journal-title":"J Intensive Care Med"},{"key":"2621_CR20","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0. 2025. https:\/\/www.eucast.org."},{"issue":"10","key":"2621_CR21","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818\u201329.","journal-title":"Crit Care Med"},{"issue":"11","key":"2621_CR22","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","volume":"26","author":"JL Vincent","year":"1998","unstructured":"Vincent JL, de Mendon\u00e7a A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med. 1998;26(11):1793\u2013800. https:\/\/doi.org\/10.1097\/00003246-199811000-00016.","journal-title":"Crit Care Med"},{"issue":"5","key":"2621_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chron Dis"},{"issue":"4","key":"2621_CR24","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, SCCM\/ESICM\/ACCP\/ATS\/SIS. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international sepsis definitions conference. Crit Care Med. 2003;31(4):1250\u20136. https:\/\/doi.org\/10.1097\/01.CCM.0000050454.01978.3B.","journal-title":"Crit Care Med"},{"issue":"6","key":"2621_CR25","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/ije\/dyw341","volume":"45","author":"J Textor","year":"2016","unstructured":"Textor J, van der Zander B, Gilthorpe MS, Liskiewicz M, Ellison GT. Robust causal inference using directed acyclic graphs: the R package \u2018dagitty.\u2019 Int J Epidemiol. 2016;45(6):1887\u201394. https:\/\/doi.org\/10.1093\/ije\/dyw341.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"2621_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/cc12616","volume":"17","author":"BH Cuthbertson","year":"2013","unstructured":"Cuthbertson BH, Elders A, Hall S, Taylor J, MacLennan G, Mackirdy F, Mackenzie SJ, Scottish Critical Care Trials Group, Scottish Intensive Care Society Audit Group. Mortality and quality of life in the five years after severe sepsis. Crit Care. 2013;17(2): R70. https:\/\/doi.org\/10.1186\/cc12616.","journal-title":"Crit Care"},{"issue":"5","key":"2621_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/MCC.0000000000001082","volume":"29","author":"AG Stewart","year":"2023","unstructured":"Stewart AG, Laupland KB, Tabah A. Central line associated and primary bloodstream infections. Curr Opin Crit Care. 2023;29(5):423\u20139. https:\/\/doi.org\/10.1097\/MCC.0000000000001082.","journal-title":"Curr Opin Crit Care"},{"issue":"2","key":"2621_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jinf.2016.11.001","volume":"74","author":"C Adrie","year":"2017","unstructured":"Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B, et al. Attributable mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance profile and antimicrobial therapy. J Infect. 2017;74(2):131\u201341. https:\/\/doi.org\/10.1016\/j.jinf.2016.11.001.","journal-title":"J Infect"},{"issue":"2","key":"2621_CR29","doi-asserted-by":"publisher","first-page":"R27","DOI":"10.1186\/cc8898","volume":"14","author":"R Abe","year":"2010","unstructured":"Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, et al. Gram-negative bacteremia induces greater magnitude of inflammatory response than gram-positive bacteremia. Crit Care. 2010;14(2):R27. https:\/\/doi.org\/10.1186\/cc8898.","journal-title":"Crit Care"},{"issue":"9","key":"2621_CR30","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.3390\/microorganisms11092357","volume":"11","author":"T Nejtek","year":"2023","unstructured":"Nejtek T, M\u00fcller M, Moravec M, Pr\u016fcha M, Zazula R. Bacteremia in patients with sepsis in the ICU: does it make a difference? Microorganisms. 2023;11(9):2357. https:\/\/doi.org\/10.3390\/microorganisms11092357.","journal-title":"Microorganisms"},{"issue":"8","key":"2621_CR31","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3390\/microorganisms12081705","volume":"12","author":"AM Oliveira","year":"2024","unstructured":"Oliveira AM, Oliveira A, Vidal R, Gon\u00e7alves-Pereira J. Infectious foci, comorbidities and its influence on the outcomes of septic critically ill patients. Microorganisms. 2024;12(8):1705. https:\/\/doi.org\/10.3390\/microorganisms12081705.","journal-title":"Microorganisms"},{"issue":"10","key":"2621_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10101648","volume":"10","author":"E Gupta","year":"2022","unstructured":"Gupta E, Kumar S, Srivastava VK, Saxena J, Siddiqui AJ, Mehta S, et al. Unravelling the differential host immuno-inflammatory responses to Staphylococcus aureus and Escherichia coli infections in sepsis. Vaccines. 2022;10(10): 1648. https:\/\/doi.org\/10.3390\/vaccines10101648.","journal-title":"Vaccines"},{"key":"2621_CR33","doi-asserted-by":"publisher","first-page":"11355","DOI":"10.1038\/srep11355","volume":"5","author":"M Surbatovic","year":"2015","unstructured":"Surbatovic M, Popovic N, Vojvodic D, Milosevic I, Acimovic G, Stojicic M, et al. Cytokine profile in severe Gram-positive and Gram-negative abdominal sepsis. Sci Rep. 2015;5:11355. https:\/\/doi.org\/10.1038\/srep11355.","journal-title":"Sci Rep"},{"issue":"4","key":"2621_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249561","volume":"16","author":"MJ J\u00e4rvisalo","year":"2021","unstructured":"J\u00e4rvisalo MJ, Hellman T, Uusalo P. Mortality and associated risk factors in patients with blood culture positive sepsis and acute kidney injury requiring continuous renal replacement therapy\u2014a retrospective study. PLoS ONE. 2021;16(4): e0249561.","journal-title":"PLoS ONE"},{"key":"2621_CR35","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268821002235","volume":"149","author":"P Xie","year":"2021","unstructured":"Xie P, Wang W, Dong M. Long-term mortality predictors of ICU fungaemia. Epidemiol Infect. 2021;149: e241. https:\/\/doi.org\/10.1017\/S0950268821002235.","journal-title":"Epidemiol Infect"},{"issue":"10","key":"2621_CR36","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1097\/CCM.0b013e3182923622","volume":"41","author":"M Palomar","year":"2013","unstructured":"Palomar M, \u00c1lvarez-Lerma F, Riera A, D\u00edaz MT, Torres F, Agra Y, Larizgoitia I, Goeschel CA, Pronovost PJ, Bacteremia Zero Working Group. Impact of a national multimodal intervention to prevent catheter-related bloodstream infection in the ICU: the Spanish experience. Crit Care Med. 2013;41(10):2364\u201372. https:\/\/doi.org\/10.1097\/CCM.0b013e3182923622.","journal-title":"Crit Care Med"},{"issue":"6","key":"2621_CR37","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.suc.2014.08.011","volume":"94","author":"MF Osman","year":"2014","unstructured":"Osman MF, Askari R. Infection control in the intensive care unit. Surg Clin North Am. 2014;94(6):1175\u201394. https:\/\/doi.org\/10.1016\/j.suc.2014.08.011.","journal-title":"Surg Clin North Am"},{"issue":"1","key":"2621_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.medin.2017.09.012","volume":"42","author":"F Chaves","year":"2018","unstructured":"Chaves F, Garnacho-Montero J, Del Pozo JL, et al. Diagnosis and treatment of catheter-related bloodstream infection: clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC). Med Intensiva. 2018;42(1):5\u201336. https:\/\/doi.org\/10.1016\/j.medin.2017.09.012.","journal-title":"Med Intensiva"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02621-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02621-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02621-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T08:53:04Z","timestamp":1764751984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02621-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2621"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02621-w","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was accepted by the hospital administration (1\/2019, 240\/2023) and the Digital and Population Data Service Agency (DVV\/5100\/2023-3). Under Finnish law, a medical registry study does not require ethics committee approval because it involves the use of existing, anonymized data collected for clinical purposes, rather than direct interaction with patients or intervention in their care. According to the Medical Research Act (488\/1999), ethical review is required for medical research involving intervention in the integrity of a person. Since registry studies do not involve such interventions, they are exempt from this requirement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}